350 related articles for article (PubMed ID: 25907296)
21. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
[TBL] [Abstract][Full Text] [Related]
22. Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/twist1 pathway.
Yin J; Wang L; Zhu JM; Yu Q; Xue RY; Fang Y; Zhang YA; Chen YJ; Liu TT; Dong L; Shen XZ
Oncotarget; 2016 Apr; 7(16):21939-51. PubMed ID: 26959880
[TBL] [Abstract][Full Text] [Related]
23. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
24. S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells.
Gao H; Zhang X; Zheng Y; Peng L; Hou J; Meng H
Mol Immunol; 2015 Oct; 67(2 Pt B):223-32. PubMed ID: 26038301
[TBL] [Abstract][Full Text] [Related]
25. Sirt6 suppresses hepatocellular carcinoma cell growth via inhibiting the extracellular signal‑regulated kinase signaling pathway.
Zhang ZG; Qin CY
Mol Med Rep; 2014 Mar; 9(3):882-8. PubMed ID: 24366394
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-17A inhibits cell autophagy under starvation and promotes cell migration via TAB2/TAB3-p38 mitogen-activated protein kinase pathways in hepatocellular carcinoma.
Zhou Y; Wu PW; Yuan XW; Li J; Shi XL
Eur Rev Med Pharmacol Sci; 2016; 20(2):250-63. PubMed ID: 26875893
[TBL] [Abstract][Full Text] [Related]
27. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways.
Sun C; Liang C; Ren Y; Zhen Y; He Z; Wang H; Tan H; Pan X; Wu Z
Basic Res Cardiol; 2009 Jan; 104(1):42-9. PubMed ID: 18622638
[TBL] [Abstract][Full Text] [Related]
28. Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.
Guo K; Liu Y; Zhou H; Dai Z; Zhang J; Sun R; Chen J; Sun Q; Lu W; Kang X; Chen P
Cancer Sci; 2008 Mar; 99(3):486-96. PubMed ID: 18167130
[TBL] [Abstract][Full Text] [Related]
29. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
[TBL] [Abstract][Full Text] [Related]
31. Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.
Yue P; Gao ZH; Xue X; Cui SX; Zhao CR; Yuan Y; Yin Z; Inagaki Y; Kokudo N; Tang W; Qu XJ
Eur J Cancer; 2011 May; 47(7):1115-24. PubMed ID: 21349701
[TBL] [Abstract][Full Text] [Related]
32. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ
World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756
[TBL] [Abstract][Full Text] [Related]
33. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
34. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.
Ehlermann P; Eggers K; Bierhaus A; Most P; Weichenhan D; Greten J; Nawroth PP; Katus HA; Remppis A
Cardiovasc Diabetol; 2006 Mar; 5():6. PubMed ID: 16573830
[TBL] [Abstract][Full Text] [Related]
35. Vitamin A (retinol) downregulates the receptor for advanced glycation endproducts (RAGE) by oxidant-dependent activation of p38 MAPK and NF-kB in human lung cancer A549 cells.
de Bittencourt Pasquali MA; Gelain DP; Zeidán-Chuliá F; Pires AS; Gasparotto J; Terra SR; Moreira JC
Cell Signal; 2013 Apr; 25(4):939-54. PubMed ID: 23333461
[TBL] [Abstract][Full Text] [Related]
36. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
37. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.
Yan F; Wang M; Li J; Cheng H; Su J; Wang X; Wu H; Xia L; Li X; Chang HC; Li Q
Environ Toxicol Pharmacol; 2012 Mar; 33(2):181-90. PubMed ID: 22222560
[TBL] [Abstract][Full Text] [Related]
38. Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE.
Narumi K; Miyakawa R; Ueda R; Hashimoto H; Yamamoto Y; Yoshida T; Aoki K
J Immunol; 2015 Jun; 194(11):5539-48. PubMed ID: 25911757
[TBL] [Abstract][Full Text] [Related]
39. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
40. RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway.
Wang S; Huang X; Li Y; Lao H; Zhang Y; Dong H; Xu W; Li JL; Li M
Hepatology; 2011 Jun; 53(6):1932-42. PubMed ID: 21391225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
